RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population

Am J Hematol 86(9):752-755 · 2011 · PMID 21786289

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

129편 검색→119편 판독→48편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Prevalence and risk factors of monoclonal gammopathy of undetermined significance in older adults Prevalence and risk factors of monoclonal gammopathy of undetermined significance in older adults

출판 연도

1995: 1편119951997: 1편120002001: 1편12002: 1편120052006: 1편12008: 2편22009: 6편62010: 2편220102011: 2편22012: 3편32013: 3편32014: 3편32015: 3편320152017: 1편12018: 5편52019: 4편42020: 1편120202021: 1편12024: 1편12025: 1편12026: 5편52026

선별된 48편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01samples · electrophoresis20편

  1. 0.95

    Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population 이 논문

    Park HK, Lee KR, Kim YJ et al. · American journal of hematology · 2011

  2. 0.94

    Prevalence of monoclonal gammopathy of undetermined significance in Thailand

    Watanaboonyongcharoen P, Nakorn TN, Rojnuckarin P et al. · International journal of hematology · 2012

  3. 0.94

    Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey

    Landgren O, Graubard BI, Katzmann JA et al. · Leukemia · 2014

  4. 0.92

    Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

    Dispenzieri A, Katzmann JA, Kyle RA et al. · Lancet (London, England) · 2010

  5. 0.91

    Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort Study

    Schmidt B, Debold E, Frank M et al. · Annals of hematology · 2019

  6. 0.91

    Occupational pesticide exposure and association of monoclonal gammopathy of undetermined significance in the Western Macroregion of Parana

    Oliota AFR, Borsa MP, da Cunha Junior AD et al. · Cancer epidemiology · 2026

  7. 0.91

    Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study

    Landgren O, Kyle RA, Hoppin JA et al. · Blood · 2009

  8. 0.90

    Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima

    Fujimura K, Sugiyama A, Akita T et al. · International journal of hematology · 2021

  9. 0.88

    Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition

    Therneau TM, Kyle RA, Melton LJ3 et al. · Mayo Clinic proceedings · 2012

  10. 0.87

    Dietary intake is associated with risk of multiple myeloma and its precursor disease

    Thordardottir M, Lindqvist EK, Lund SH et al. · PloS one · 2018

  11. 0.86

    Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

    Vachon CM, Kyle RA, Therneau TM et al. · Blood · 2009

  12. 0.83

    Metabolic syndrome and risk of monoclonal gammopathy of undetermined significance: a large Korean cohort study

    Lee JY, Jung EJ, Kwon S et al. · Haematologica · 2026

  13. 0.83

    Association between the delta estimated glomerular filtration rate and the prevalence of monoclonal gammopathy of undetermined significance in Korean males

    Jeong TD, Lee W, Chun S et al. · BioMed research international · 2014

  14. 0.83

    Prevalence of Monoclonal Gammopathy of Undetermined Significance in India-A Hospital-based Study

    Gupta R, Dahiya M, Kumar L et al. · Clinical lymphoma, myeloma & leukemia · 2018

  15. 0.83

    Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster

    Landgren O, Zeig-Owens R, Giricz O et al. · JAMA oncology · 2018

  16. 0.71

    Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM

    Zwick C, Held G, Auth M et al. · International journal of cancer · 2014

  17. 0.69

    Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma

    Greenberg AJ, Lee AM, Serie DJ et al. · Leukemia · 2013

  18. 0.68

    Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS

    Katzmann JA, Clark R, Kyle RA et al. · Leukemia · 2013

  19. 0.61

    Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

    Landgren O, Hofmann JN, McShane CM et al. · JAMA oncology · 2019

  20. 0.56

    Abnormal Plasma Cell Disorders in Refinery Waste Workers

    Ledda C, Loreto C, Filetti V et al. · Journal of clinical medicine · 2018

02lymphoma · relative15편

  1. 0.87

    Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics

    Clay-Gilmour AI, Kumar S, Rajkumar SV et al. · Leukemia · 2019

  2. 0.86

    Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden

    Rognvaldsson S, Thorsteinsdottir S, Syriopoulou E et al. · Haematologica · 2024

  3. 0.71

    The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance

    Gregersen H, Mellemkjaer L, Ibsen JS et al. · Haematologica · 2001

  4. 0.66

    Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden

    Kristinsson SY, Bjorkholm M, Goldin LR et al. · Blood · 2008

  5. 0.64

    A long-term study of prognosis in monoclonal gammopathy of undetermined significance

    Kyle RA, Therneau TM, Rajkumar SV et al. · The New England journal of medicine · 2002

  6. 0.62

    Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden

    Kristinsson SY, Bjorkholm M, Goldin LR et al. · International journal of cancer · 2009

  7. 0.62

    Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance

    Pasqualetti P, Casale R · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 1997

  8. 0.61

    Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

    Kyle RA, Larson DR, Therneau TM et al. · The New England journal of medicine · 2018

  9. 0.58

    Long-term follow-up of a population based cohort with monoclonal proteinaemia

    Schaar CG, le Cessie S, Snijder S et al. · British journal of haematology · 2009

  10. 0.56

    Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

    Landgren O, Kristinsson SY, Goldin LR et al. · Blood · 2009

  11. 0.55

    Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients

    Za T, De Stefano V, Rossi E et al. · British journal of haematology · 2013

  12. 0.53

    Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands

    van de Poel MH, Coebergh JW, Hillen HF · British journal of haematology · 1995

  13. 0.53

    Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience

    Alfano G, Fontana F, Colaci E et al. · Transplantation · 2017

  14. 0.52

    Familial paraproteinemia: hyper-responsive B-cells as endophenotype

    Ogmundsdottir HM, Steingrimsdottir H, Haraldsdottir V · Clinical lymphoma, myeloma & leukemia · 2011

  15. 0.51

    Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies

    Galioto A, Morando F, Rosi S et al. · Transplant international : official journal of the European Society for Organ Transplantation · 2012

03veterans · race9편

  1. 0.94

    MGUS in Black individuals in Soweto, South Africa screened by mass spectrometry: results of the PROMISE South Africa study

    Lee DJ, Chen WC, Bertamini L et al. · EClinicalMedicine · 2026

  2. 0.93

    Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

    Landgren O, Rajkumar SV, Pfeiffer RM et al. · Blood · 2010

  3. 0.90

    Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study

    Landgren O, Shim YK, Michalek J et al. · JAMA oncology · 2015

  4. 0.89

    Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States

    Landgren O, Gridley G, Turesson I et al. · Blood · 2006

  5. 0.88

    Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors

    Iwanaga M, Tagawa M, Tsukasaki K et al. · Blood · 2009

  6. 0.76

    Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders

    Brown LM, Gridley G, Check D et al. · Blood · 2008

  7. 0.64

    Cumulative Excess Body Mass Index and MGUS Progression to Myeloma

    Liu L, Grandhi N, Wang M et al. · JAMA network open · 2025

  8. 0.57

    Association and Prognostic Significance of Comorbidities in Individuals With MGUS

    Bawek S, Nassour N, Alharbi M et al. · Clinical lymphoma, myeloma & leukemia · 2026

  9. 0.54

    Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study

    Chang SH, Luo S, O'Brian KK et al. · The Lancet. Haematology · 2015

04disease · therapy4편

  1. 0.90

    The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions

    Atkin C, Reddy-Kolanu V, Drayson MT et al. · British journal of haematology · 2020

  2. 0.89

    Dietary intake and the risk of monoclonal gammopathy of undetermined significance: results from the population-based iStopMM screening study

    Hallsson S, Gunnarsdottir I, Thordardottir M et al. · Blood cancer journal · 2026

  3. 0.71

    Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma

    Caviglia GP, Sciacca C, Abate ML et al. · Journal of gastroenterology and hepatology · 2015

  4. 0.71

    Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies

    Kumar S, Larson DR, Dispenzieri A et al. · Blood cancer journal · 2019